fda enforcement actions bpc-157 compounding pharmacies is reviewing seven peptides this week, BPC-157, MOTS-c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on pharmacies. Read past the headline BPC-157 FDA Approval Status: Is

The phosphinic pseudotripeptide series of compounds designed from structural and mechanistic knowledge of IRAP and the related ERAP1 and ERAP2 are promising and some of them exert powerful IRAP inhibitory effects

The math is the same: total mg divided by total mL equals mg/mL

Principal component analysis (PCA) indicated that Day 30 iHLOs exhibited a protein expression pattern more closely aligned with human liver tissue than HepaRG and HepG2 cells (Fig

Instead of offering a generic protocol, the team builds a personalized plan that may include: Targeted peptide therapy such as Semax, Dihexa, or other neuro-supportive compounds

Proteomic analysis of Day 30s iHLOs showed a decline in AFP expression, accompanied by a substantial upregulation of markers associated with mature hepatocytes such as CYP3A4 and UDP-glucuronosyltransferase 1A1 (UGT1A1)